Lin Lv

661 total citations
22 papers, 555 citations indexed

About

Lin Lv is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Lin Lv has authored 22 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Lin Lv's work include Cardiac Fibrosis and Remodeling (6 papers), Retinal Diseases and Treatments (2 papers) and Traditional Chinese Medicine Analysis (2 papers). Lin Lv is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), Retinal Diseases and Treatments (2 papers) and Traditional Chinese Medicine Analysis (2 papers). Lin Lv collaborates with scholars based in China, Australia and Germany. Lin Lv's co-authors include De-min Yu, Chunjun Li, Hui Li, Kai Chen, Shaoyu Wu, Guohua Zhang, Saijun Zhou, Yuxin Zhuang, Pei Yu and Pei Yu and has published in prestigious journals such as Neuroscience, Journal of Ethnopharmacology and Waste Management.

In The Last Decade

Lin Lv

22 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Lv China 11 269 138 119 75 70 22 555
Jiangyang Chi China 12 424 1.6× 128 0.9× 111 0.9× 89 1.2× 66 0.9× 20 742
Chia-Yao Shen Taiwan 19 387 1.4× 164 1.2× 90 0.8× 56 0.7× 104 1.5× 39 836
Xiangli Bai China 16 449 1.7× 118 0.9× 138 1.2× 95 1.3× 69 1.0× 24 769
Xue-Fen Pang China 11 162 0.6× 102 0.7× 81 0.7× 35 0.5× 42 0.6× 13 468
Gema Marín‐Royo Spain 8 176 0.7× 101 0.7× 132 1.1× 71 0.9× 32 0.5× 11 520
Xuexue Zhu China 14 315 1.2× 76 0.6× 51 0.4× 99 1.3× 80 1.1× 39 667
Liwei Ren China 14 282 1.0× 196 1.4× 168 1.4× 113 1.5× 42 0.6× 30 574
Lin-Lin Kang China 7 386 1.4× 59 0.4× 141 1.2× 67 0.9× 58 0.8× 7 723
Gao Xu China 7 202 0.8× 84 0.6× 52 0.4× 70 0.9× 41 0.6× 7 404

Countries citing papers authored by Lin Lv

Since Specialization
Citations

This map shows the geographic impact of Lin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lv more than expected).

Fields of papers citing papers by Lin Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lv. The network helps show where Lin Lv may publish in the future.

Co-authorship network of co-authors of Lin Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Lv. A scholar is included among the top collaborators of Lin Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Lv. Lin Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xi, et al.. (2025). Exploring undergraduate medical students and faculty perspectives on blended learning: a qualitative study in China. BMJ Open. 15(1). e089612–e089612. 1 indexed citations
2.
Lv, Lin, Yue Long, Qi Xiao, et al.. (2025). Host-mediated environmental microbiome recruitment by black soldier fly (Hermetia illucens) enhances waste biotransformation. Waste Management. 204. 114886–114886. 3 indexed citations
3.
Lv, Lin, et al.. (2025). Therapeutic inhibition of PHF21B attenuates pathological cardiac hypertrophy by inhibiting the BMP4/GSK3β/β-catenin axis. European Journal of Pharmacology. 991. 177346–177346. 1 indexed citations
5.
Chen, Kai, Jingru Zhang, Xin Liu, et al.. (2021). Modulation of transforming growth factor-beta signaling pathway mediates the effects of Kangxian Formula on cardiac remodeling. Journal of Ethnopharmacology. 272. 113922–113922. 3 indexed citations
6.
Bao, Yangyang, et al.. (2021). Conophylline Suppresses Angiotensin II-Induced Myocardial Fibrosis In Vitro via the BMP4/JNK Pathway. Bulletin of Experimental Biology and Medicine. 171(3). 305–311. 3 indexed citations
7.
Chen, Kai, et al.. (2019). Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE−/− mice. Biomedicine & Pharmacotherapy. 113. 108753–108753. 87 indexed citations
8.
Liu, Xin, Kai Chen, Yuxin Zhuang, et al.. (2019). Paeoniflorin improves pressure overload-induced cardiac remodeling by modulating the MAPK signaling pathway in spontaneously hypertensive rats. Biomedicine & Pharmacotherapy. 111. 695–704. 51 indexed citations
9.
Chen, Kai, et al.. (2019). Danshenol A Alleviates Hypertension-Induced Cardiac Remodeling by Ameliorating Mitochondrial Dysfunction and Suppressing Reactive Oxygen Species Production. Oxidative Medicine and Cellular Longevity. 2019. 1–18. 8 indexed citations
10.
Deng, Yan, Yingbao Yang, Jinjun Rao, et al.. (2015). Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode. BMC Complementary and Alternative Medicine. 16(1). 56–56. 20 indexed citations
11.
Zhang, Xiaoli, et al.. (2015). Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway. Anti-Cancer Agents in Medicinal Chemistry. 15(6). 755–763. 27 indexed citations
13.
Zhou, Saijun, Rui Chen, Lin Lv, et al.. (2014). Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling. Molecular Medicine Reports. 11(3). 2167–2172. 7 indexed citations
14.
Liu, Hongyan, Saijun Zhou, Gareth Denyer, et al.. (2014). Reduced β-2-glycoprotein І inhibits hypoxia-induced retinal angiogenesis in neonatal mice through the vascular endothelial growth factor pathway. Molecular Medicine Reports. 11(2). 1025–1030. 6 indexed citations
16.
Mao, Nan, et al.. (2014). [Effect of silencing Bmi-1 expression in reversing cisplatin resistance in lung cancer cells and its mechanism].. PubMed. 34(7). 1000–4. 2 indexed citations
17.
Wang, Weilin, Saijun Zhou, Chunjun Li, et al.. (2013). Reduced beta2-glycoprotein I protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis. Lipids in Health and Disease. 12(1). 174–174. 13 indexed citations
18.
Zhang, Rui, Saijun Zhou, Chunjun Li, et al.. (2013). C-reactive protein/oxidised low-density lipoprotein/β2-glycoprotein I complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway. Lipids in Health and Disease. 12(1). 42–42. 24 indexed citations
19.
20.
Li, Chunjun, Lin Lv, Hui Li, & De-min Yu. (2012). Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovascular Diabetology. 11(1). 73–73. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026